FOLFOXIRI protocol: Clinical Trials

7 trials of FOLFOXIRI protocol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 unknown, 1 completed, 1 not yet recruiting. 7 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 37Recruiting 3, Unknown 2, Completed 1, Not yet recruiting 1

Follow FOLFOXIRI protocol: new trials by email Literature Review of FOLFOXIRI protocol trials Research Report on FOLFOXIRI protocol

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer
FOLFOXIRI, CAPOX, FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin) - Locally Advanced Rectal Carcinoma
Phase 3RecruitingJ. W. A. Burger3942026-03-162026-10-27
Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer
FOLFOXIRI, CapeOX - Rectal Cancer
Phase 3RecruitingFudan University3002021-08-272022-03-04
Brazilian Total Neoadjuvant Therapy Trial
Folfirinox - Colorectal Neoplasms
Phase 3UnknownHospital Israelita Albert Einstein1502020-02-202023-10-11
Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Chemoradiation, FOLFOXIRI Protocol, Folfox Protocol - Rectal Cancer, Chemotherapy Effect
Phase 3Not yet recruitingSixth Affiliated Hospital, Sun Yat-sen University9332019-08-012019-06-05
Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation
FOLFOXIRI, XELOX, Chemoradiotherapy - Rectal Cancer
Phase 3RecruitingSun Yat-sen University7762018-11-162019-01-23
Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer
FOLFOXIRI, Gemcitabine - Pancreatic Cancer
Phase 3UnknownAzienda Ospedaliero, Universitaria Pisana3102015-01-012015-02-04
FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer
FOLFIRI, FOLFOXIRI - Metastatic Colorectal Cancer
Phase 3CompletedGruppo Oncologico del Nord-Ovest2442001-11-012015-03-11

Conditions studied

Rectal Neoplasms (4)  ·  Colorectal Neoplasms (2)  ·  Pancreatic Neoplasms (1)  ·  Pathologic Complete Response (1)

Sponsors

Azienda Ospedaliero, Universitaria Pisana (1)  ·  Fudan University (1)  ·  Gruppo Oncologico del Nord-Ovest (1)  ·  Hospital Israelita Albert Einstein (1)  ·  J. W. A. Burger (1)  ·  Sixth Affiliated Hospital, Sun Yat-sen University (1)  ·  Sun Yat-sen University (1)

Countries

China (2)  ·  Italy (2)  ·  Brazil (1)  ·  Netherlands (1)

Top investigators

Alfredo Falcone, MD (1)  ·  Diogo Gomes, MD (1)  ·  Enrico Vasile, MD, PhD (1)  ·  Jacobus WA Burger, Prof. dr. (1)  ·  Ping Lan, MD (1)  ·  Rui-hua Xu (1)  ·  Ye Xu (1)

Results publications

PMID 26861604, PMID 42151882

NIH funding

2025 (1)